Update on the ophthalmic management of facial paralysis

Survey of Ophthalmology

Volumn 64, Issue 1, 2019, Pages 79-89

  MacIntosh, Peter W ^a   Fay, Aaron M ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

BELL PALSY; CORNEA ULCER; EYE CARE; FACIAL NERVE PARALYSIS; HUMAN; IDIOPATHIC DISEASE; KERATOPATHY; LAGOPHTHALMOS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SHORT COURSE THERAPY; STEROID THERAPY; DISEASE MANAGEMENT; OPHTHALMOLOGY; PROCEDURES;

DISEASE MANAGEMENT; FACIAL PARALYSIS; HUMANS; OPHTHALMOLOGY;

EID: 85050877928     PISSN: 00396257     EISSN: 18793304     Source Type: Journal    
DOI: 10.1016/j.survophthal.2018.06.001     Document Type: Review

References (56)

1. Adour, K.K., Byl, F.M., Hilsinger, R.L., Kahn, Z.M., Sheldon, M.I., The true nature of Bell's palsy: analysis of 1,000 consecutive patients. Laryngoscope 88:5 (1978), 787–801.
2. Aggarwal, E., Naik, M.N., Honavar, S.G., Effectiveness of the gold weight trial procedure in predicting the ideal weight for lid loading in facial palsy: a prospective study. Am J Ophthalmol 143:6 (2007), 1009–1012.
3. American Academy of Neurology summary of evidence-based guideline for clinicians, Update: Steroids and Antivirals for Bell Palsy. https://www.aan.com/Guidelines/home/GetGuidelineContent/574, 2012. (Accessed 13 February 2018)
4. American Academy of Ophthalmology Bell's palsy treatment. www.aao.org/eye-health/diseases/bells-palsy-treatment, 2017. (Accessed 13 February 2018)
5. American Academy of Otolaryngology – Head and Neck Surgery clinical practice guideline, Bell's Palsy. http://www.entnet.org/sites/default/files/October2013_BellsGuidelineFactSheet.pdf, 2013. (Accessed 13 February 2018)
6. Barmettler, A., Nissanka, N., Rosenblatt, M.I., Rao, R., Lipson, D., Lelli, G.J., Magnetic systems for tarsorrhaphy. Ophthal Plast Reconstr Surg 30:4 (2014), 305–308.
7. Berghaus, A., Neuman, K., Schrom, T., The platinum chain. A new upper-lid implant for facial palsy. Arch Facial Plast Surg 5 (2003), 166–170.
8. Björkner, B., Bruze, M., Möller, H., et al. Allergic contact dermatitis as a complication of lid loading with gold implants. Dermatitis, 19, 2008, 148.e53.
9. Bladen, J.C., Norris, J.H., Malhotra, R., Indications and outcomes for revision of gold weight implants in upper eyelid loading. Br J Ophthalmol 96 (2012), 485–489.
10. Cabin, J.A., Massry, G.G., Azizzadeh, B., Botulinum toxin in the management of facial paralysis. Curr Opin Otolaryngol Head Neck Surg 23:4 (2015), 272–280.
11. Centers for Disease Control and Prevention Reported cases of Lyme disease by state or locality, 2006–2016. https://www.cdc.gov/lyme/stats/tables.html, 2016. (Accessed 13 February 2018)
12. Cronin, G.W., Steenerson, R.L., The effectiveness of neuromuscular facial retraining combined with electromyography in facial paralysis rehabilitation. Otolaryngol Head Neck Surg 128:4 (2003), 534–538.
13. Dickins, J.R., Smith, J.T., Graham, S.S., Herpes zoster oticus: treatment with intravenous acyclovir. Laryngoscope 98:7 (1988), 776–779.
14. Diels, H.J., Combs, D., Neuromuscular retraining for facial paralysis. Otolaryngol Clin North Am 30:5 (1997), 727–743.
15. Diels, H.J., Facial paralysis: Is there a role for a therapist?. Facial Plast Surg 16:4 (2001), 361–364.
16. Engström, M., Berg, T., Stjernquist-Desatnik, A., et al. Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol 7:11 (2008), 993–1000.
17. Gaudin, R.A., Robinson, M., Banks, C.A., Baiungo, J., Jowett, N., Hadlock, T.A., Emerging vs time-tested methods of facial grading among patients with facial paralysis. JAMA Facial Plast Surg 18:4 (2016), 251–257.
18. Gire, A., Kwok, A., Marx, D.P., PROSE treatment for lagophthalmos and exposure keratopathy. Ophthal Plast Reconstr Surg 29:2 (2013), e38–e40.
19. Graham, M.D., Kartush, J.M., Total facial nerve decompression for recurrent facial paralysis: an update. Otolaryngol Head Neck Surg 101:4 (1989), 442–444.
20. Griffin, G., Fay, A., Azizzadeh, B., Facial nerve palsy. Fay, A., Dolman, P.J., (eds.) Diseases and Disorders of the Orbit and Ocular Adnexa, 2016, Elsevier, New York, NY, 580–603.
21. Hadlock, T.A., Cheney, M.L., Impaired facial movement: paralysis, synkinesis, and spasm. Cheney, M.L., Hadlock, T.A., (eds.) Facial Surgery. Plastic and Reconstructive, 2015, CRC Press, New York, NY, 931–968.
22. Hadlock, T.A., Urban, L.S., Toward a universal, automated facial measurement tool in facial reanimation. Arch Facial Plast Surg 14:4 (2012), 277–282.
23. Halperin, J.J., Shapiro, E.D., Logigian, E., et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 69:1 (2007), 91–102.
24. Hato, N., Murakami, S., Gyo, K., et al. Steroid and antiviral treatment for Bell's palsy. Lancet 371:9627 (2008), 1818–1820.
25. Hohman, M.H., Hadlock, T.A., Etiology, diagnosis, and management of facial palsy: 2000 patients at a facial nerve center. Laryngoscope 124 (2014), E283–E293.
26. Hohman, M.H., Silver, A.L., Henstrom, D.K., Cheney, M.L., Hadlock, T.A., The “power” brow lift: Efficient correction of the paralyzed brow. ISRN Plast Surg, 2013, 2013 Article ID 735406.
27. House, J.W., Brackman, D.E., Facial nerve grading system. Otolaryngol Head Neck Surg 93 (1985), 146–147.
28. Jowett, N., Gaudin, R.A., Banks, C.A., Hadlock, T.A., Steroid use in lyme disease-associated facial palsy is associated with worse long-term outcomes. Laryngoscope 127:6 (2017), 1451–1458.
29. Kanaya, K., Ushio, M., Kondo, K., et al. Recovery of facial movement and facial synkinesis in Bell's palsy patients. Otol Neurotol 30:5 (2009), 640–644.
30. Keczkes, K., Basheer, A.M., Do corticosteroids prevent post-herpetic neuralgia?. Br J Dermatol 102:5 (1980), 551–555.
31. Kelley, S.A., Sharpe, D.T., Gold eyelid weights in patients with facial palsy: a patient review. Plast Reconstr Surg 89:3 (1992), 436–440.
32. Kim, H.J., Jung, J., Kim, S.S., Byun, J.Y., Park, M.S., Yeo, S.G., Comparison of acyclovir and famcyclovir for Ramsay Hunt syndrome. Otol Neurotol 38:5 (2017), 754–758.
33. Kinishi, M., Amatsu, M., Mohri, M., Saito, M., Hasegawa, T., Hasegawa, S., Acyclovir improves recovery rate of facial nerve palsy in Ramsay Hunt syndrome. Auris Nasus Larynx 28 (2001), 223–226.
34. Levine, R.E., Shapiro, J.P., Reanimation of the paralyzed eyelid with the enhanced palpebral spring or the gold weight: modern replacements for tarsorrhaphy. Facial Plast Surg 16:4 (2001), 325–336.
35. Lyme Disease (Borrelia burgdorferi) 2017 Case Definition. https://wwwn.cdc.gov/nndss/conditions/lyme-disease/case-definition/2017/, 2017. (Accessed 28 November 2017)
36. Mavrikakis, I., Malhotra, R., Techniques for upper eyelid loading. Ophthal Plast Reconstr Surg 22:5 (2006), 325–330.
37. Malhotra, R., Ziahosseini, K., Litwin, A., Nduka, C., El-Shammah, N., CADS grading scale: towards better grading of ophthalmic involvement in facial nerve paralysis. Br J Ophthalmol 100 (2016), 866–870.
38. McCormick, D.P., Herpes-simplex virus as a cause of Bell's palsy. Lancet 1:7757 (1972), 937–939.
39. Monini, S., De Carlo, A., Biagini, M., et al. Combined protocol for treatment of secondary effects from facial nerve palsy. Acta Otolaryngol 131:8 (2011), 882–886.
40. Murakami, S., Mizobuchi, M., Nakashiro, Y., Doi, T., Hato, N., Yanagihara, N., Bell's palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med 124:1 Pt 1 (1996), 27–30.
41. Naik, M.N., Gangogadhyay, N., Fernandes, M., Murthy, R., Honavar, S.G., Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection. Eye (Lond) 22:9 (2008), 1132–1136.
42. Peitersen, E., Bell's palsy: the spontaneous course of 2, 500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 549 (2002), 4–30.
43. Pickford, M.A., Scamp, T., Harrison, D.H., Morbidity after gold weight insertion into the upper eyelid in facial palsy. Br J Plast Surg 45:6 (1992), 460–464.
44. Reuler, J.B., Chang, M.K., Herpes zoster: epidemiology, clinical features, and management. South Med J 77:9 (1984), 1149–1156.
45. Rofagha, S., Seiff, S.R., Long-term results for the use of gold eyelid load weights in the management of facial paralysis. Plast Reconstr Surg, 125, 2010, 142.e9.
46. Ross, B.G., Fradet, G., Nedzelski, J.M., Development of a sensitive clinical facial grading system. Otolaryngol Head Neck Surg 114:3 (1996), 380–386.
47. Saleh, G.M., Mavrikakis, I., de Sousa, J.L., et al. Corneal astigmatism with upper eyelid gold weight implantation using the combined high pretarsal. Ophthalmic Plast Reconstr Surg 23:5 (2007), 381–383.
48. Shaitkin, B.M., May, M., Klein, S.R., Office evaluation of the patient with facial palsy: Differential diagnosis and prognosis. May, M., Schaitkin, B.M., (eds.) The Facial Nerve, 2nd ed, 2000, Thieme, New York, NY, 179–212.
49. Schaitkin, B., May, M., Klein, S., The Facial Nerve. 2nd ed., 2000, Thieme, New York, NY.
50. Siah, W.F., Nagendran, S., Tan, P., Ahmad, S.M.A., Litwin, A.S., Malhotra, R., Late outcomes of gold weights and platinum chains for upper eyelid loading. Br J Ophthalmol 102 (2018), 164–168.
51. Smellie, G.D., Restoration of the blinking reflex in facial palsy by a simple lid-loading operation. Br J Plast Surg 19 (1966), 279–283.
52. Sönmez, A., Oztürk, N., Durmus, N., et al. Patients’ perspectives on the ocular symptoms of facial paralysis after gold weight implantation. J Plast Reconstr Aesthet Surg, 61, 2008, 1065.e8.
53. Sullivan, F.M., Swan, I.R.C., Donnan, P.T., et al. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med 357:16 (2007), 1598–1607.
54. Terzis, J.K., Kyere, S.A., Experience with the gold weight and palpebral spring in the management of paralytic lagophthalmos. Plast Reconstr Surg 121:3 (2008), 806–815.
55. Treatment of lyme disease. JAMA 315:22 (2016), 2461–2462.
56. Wagh, V.K., Lim, W.S., Cascone, N.C., Morley, A.M.S., Post-septal upper eyelid loading for treatment of exposure keratopathy secondary to non-cicatricial lagophthalmos. Orbit 35:5 (2016), 239–244.